By Regulatory Approvals — Recon: FDA approves Zenbexus for multiple myeloma; NSAI seeks buyer for its MDR notified body business RAPS
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 17, 2026.